Magalhães Luis Eduardo, Favarin Ana Júlia, Cardoso Pedro Andriolo, Yuasa Bruna Kaori, Zamoner Welder, Balbi André Luís, Ponce Daniela
Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.
Einstein (Sao Paulo). 2024 Sep 30;22:eAO0687. doi: 10.31744/einstein_journal/2024AO0687. eCollection 2024.
Magalhães et al. demonstrated that the incidence of acute kidney injury was high in hospitalized patients with COVID-19 and that the second wave was associated with greater severity; however, the mortality rates were similar between the two periods. This may reflect both the effectiveness of vaccines and the constant learning that frontline professionals gained throughout the pandemic to provide greater support to their patients.
◼ Renal involvement was frequent in patients with COVID-19 and related to worse outcomes.
◼ Diuretic use, mechanical ventilation, proteinuria, hematuria, age, and creatine phosphokinase and D-dimer levels were risk factors for acute kidney injury.
◼ Acute kidney injury, mechanical ventilation, elevated SOFA Score, and elevated ATN-ISS were associated with mortality.
◼ The second wave was associated with greater severity; however, the mortality rates were similar between the two periods.
◼ This may reflect the effectiveness of vaccines and the constant learning that frontline professionals gained throughout the pandemic.
This study aimed to evaluate the incidence of acute kidney injury in hospitalized Brazilian patients with COVID-19 and identify the risk factors associated with its development and prognosis during the two waves of the disease.
We performed a prospective cohort study of hospitalized patients with COVID-19 at a public university hospital in São Paulo from March 2020 to May 2021.
Of 887 patients hospitalized with COVID-19, 54.6% were admitted to the intensive care unit. The incidence of acute kidney injury was 48.1%, and the overall mortality rate was 38.9%. Acute kidney replacement therapy was indicated for 58.8% of the patients. The factors associated with acute kidney injury were diuretic use (odds ratio [OR] 2.2, 95%CI= 1.2-4.1, p=0.01), mechanical ventilation (OR= 12.9, 95%CI= 4.3-38.2, p<0.0001), hematuria(OR= 2.02, 95%CI= 1.1-3.5, p<0.0001), chronic kidney disease (OR= 2.6, 95%CI= 1.2-5.5, p=0.009), age (OR= 1.03, 95%CI= 1.01-1.07, p=0.02), and elevated creatine phosphokinase (OR= 1.02, 95%CI= 1.01-1.07, p=0.02) and D-dimer levels (OR= 1.01, 95%CI= 1.01-1.09, p<0.0001). Mortality was higher among those with acute kidney injury (OR= 1.12, 95%CI= 1.02-2.05, p=0.01), elevated Sequential Organ Failure Assessment Scores (OR= 1.35, 95%CI= 1.1-1.6, p=0.007), elevated Acute Tubular Necrosis-Injury Severity Score (ATN-ISS; (OR= 96.4, 95%CI= 4.8-203.1, p<0.0001), and who received mechanical ventilation (OR= 12.9, 95%CI= 4.3-38.2, p<0.0001). During the second wave, the number of cases requiring mechanical ventilation (OR= 1.57, 95%CI= 1.01-2.3, p=0.026), with proteinuria (OR= 1.44, 95%CI= 1.01-2.1, p=0.04), and with higher ATN-ISS Scores (OR= 40.9, 95%CI= 1.7-48.1, p=0.04) was higher than that during the first wave.
Acute kidney injury was frequent in hospitalized patients with COVID-19, and the second wave was associated with greater severity. However, mortality rates were similar between the two periods, which may reflect both the effectiveness of vaccines and the constant learning that frontline professionals gained throughout the pandemic to provide greater support to their patients.
RBR-62y3h7.
马加良斯等人证明,新冠病毒疾病(COVID-19)住院患者急性肾损伤的发生率很高,且第二波疫情相关的病情更严重;然而,两个时期的死亡率相似。这可能既反映了疫苗的有效性,也体现了一线专业人员在整个疫情期间不断积累的经验,从而能为患者提供更多支持。
◼ COVID-19患者经常出现肾脏受累,且与更差的预后相关。
◼ 使用利尿剂、机械通气、蛋白尿、血尿、年龄以及肌酸磷酸激酶和D-二聚体水平是急性肾损伤的危险因素。
◼ 急性肾损伤、机械通气、序贯器官衰竭评估(SOFA)评分升高和急性肾小管坏死损伤严重程度评分(ATN-ISS)升高与死亡率相关。
◼ 第二波疫情相关的病情更严重;然而,两个时期的死亡率相似。
◼ 这可能反映了疫苗的有效性以及一线专业人员在整个疫情期间不断积累的经验。
本研究旨在评估巴西COVID-19住院患者急性肾损伤的发生率,并确定在疫情的两波期间与其发生和预后相关的危险因素。
我们对2020年3月至2021年5月在圣保罗一所公立大学医院住院的COVID-19患者进行了一项前瞻性队列研究。
在887例COVID-19住院患者中,54.6%入住重症监护病房。急性肾损伤的发生率为48.1%,总死亡率为38.9%。58.8%的患者需要进行急性肾替代治疗。与急性肾损伤相关的因素包括使用利尿剂(比值比[OR] 2.2,95%置信区间[CI]= 1.2 - 4.1,p = 0.01)、机械通气(OR = 12.9,95%CI = 4.3 - 38.2,p < 0.0001)、血尿(OR = 2.02,95%CI = 1.1 - 3.5,p < 0.0001)、慢性肾病(OR = 2.6,95%CI = 1.2 - 5.5,p = 0.009)、年龄(OR = 1.03,95%CI = 1.01 - 1.07,p = 0.02)以及肌酸磷酸激酶升高(OR = 1.02,95%CI = 1.01 - 1.07,p = 0.02)和D-二聚体水平升高(OR = 1.01,95%CI = 1.01 - 1.09,p < 0.0001)。急性肾损伤患者的死亡率更高(OR = 1.12,95%CI = 1.02 - 2.05,p =